BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 33979648)

  • 1. Targeting SUMOylation dependency in human cancer stem cells through a unique SAE2 motif revealed by chemical genomics.
    Benoit YD; Mitchell RR; Wang W; Orlando L; Boyd AL; Tanasijevic B; Aslostovar L; Shapovalova Z; Doyle M; Bergin CJ; Vojnits K; Casado FL; Di Lu J; Porras DP; García-Rodriguez JL; Russell J; Zouggar A; Masibag AN; Caba C; Koteva K; Kinthada LK; Patel JS; Andres SN; Magolan J; Collins TJ; Wright GD; Bhatia M
    Cell Chem Biol; 2021 Oct; 28(10):1394-1406.e10. PubMed ID: 33979648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.
    Kessler JD; Kahle KT; Sun T; Meerbrey KL; Schlabach MR; Schmitt EM; Skinner SO; Xu Q; Li MZ; Hartman ZC; Rao M; Yu P; Dominguez-Vidana R; Liang AC; Solimini NL; Bernardi RJ; Yu B; Hsu T; Golding I; Luo J; Osborne CK; Creighton CJ; Hilsenbeck SG; Schiff R; Shaw CA; Elledge SJ; Westbrook TF
    Science; 2012 Jan; 335(6066):348-53. PubMed ID: 22157079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumoylation of SAE2 C terminus regulates SAE nuclear localization.
    Truong K; Lee TD; Li B; Chen Y
    J Biol Chem; 2012 Dec; 287(51):42611-9. PubMed ID: 23095757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversification of SUMO-activating enzyme in Arabidopsis: implications in SUMO conjugation.
    Castaño-Miquel L; Seguí J; Manrique S; Teixeira I; Carretero-Paulet L; Atencio F; Lois LM
    Mol Plant; 2013 Sep; 6(5):1646-60. PubMed ID: 23482370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation.
    Licciardello MP; Müllner MK; Dürnberger G; Kerzendorfer C; Boidol B; Trefzer C; Sdelci S; Berg T; Penz T; Schuster M; Bock C; Kralovics R; Superti-Furga G; Colinge J; Nijman SM; Kubicek S
    Oncogene; 2015 Jul; 34(29):3780-90. PubMed ID: 25263445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
    Truong K; Lee TD; Chen Y
    J Biol Chem; 2012 May; 287(19):15154-63. PubMed ID: 22403398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sam68 Allows Selective Targeting of Human Cancer Stem Cells.
    Benoit YD; Mitchell RR; Risueño RM; Orlando L; Tanasijevic B; Boyd AL; Aslostovar L; Salci KR; Shapovalova Z; Russell J; Eguchi M; Golubeva D; Graham M; Xenocostas A; Trus MR; Foley R; Leber B; Collins TJ; Bhatia M
    Cell Chem Biol; 2017 Jul; 24(7):833-844.e9. PubMed ID: 28648376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
    Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
    J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMOylation of E2F1 Regulates Expression of EZH2.
    Du L; Fakih MG; Rosen ST; Chen Y
    Cancer Res; 2020 Oct; 80(19):4212-4223. PubMed ID: 32816857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal.
    Du L; Li YJ; Fakih M; Wiatrek RL; Duldulao M; Chen Z; Chu P; Garcia-Aguilar J; Chen Y
    Nat Commun; 2016 Jul; 7():12326. PubMed ID: 27465491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versatile recombinant SUMOylation system for the production of SUMO-modified protein.
    Weber AR; Schuermann D; Schär P
    PLoS One; 2014; 9(7):e102157. PubMed ID: 25007328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting SUMO Signaling to Wrestle Cancer.
    Kroonen JS; Vertegaal ACO
    Trends Cancer; 2021 Jun; 7(6):496-510. PubMed ID: 33353838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of curcumin, a natural product in turmeric, on Burkitt lymphoma and acute myeloid leukemia cancer stem cell markers.
    Li Y; Domina A; Lim G; Chang T; Zhang T
    Future Oncol; 2018 Oct; 14(23):2353-2360. PubMed ID: 30139269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer.
    Langston SP; Grossman S; England D; Afroze R; Bence N; Bowman D; Bump N; Chau R; Chuang BC; Claiborne C; Cohen L; Connolly K; Duffey M; Durvasula N; Freeze S; Gallery M; Galvin K; Gaulin J; Gershman R; Greenspan P; Grieves J; Guo J; Gulavita N; Hailu S; He X; Hoar K; Hu Y; Hu Z; Ito M; Kim MS; Lane SW; Lok D; Lublinsky A; Mallender W; McIntyre C; Minissale J; Mizutani H; Mizutani M; Molchinova N; Ono K; Patil A; Qian M; Riceberg J; Shindi V; Sintchak MD; Song K; Soucy T; Wang Y; Xu H; Yang X; Zawadzka A; Zhang J; Pulukuri SM
    J Med Chem; 2021 Mar; 64(5):2501-2520. PubMed ID: 33631934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation.
    Boggio R; Passafaro A; Chiocca S
    J Biol Chem; 2007 May; 282(21):15376-82. PubMed ID: 17392274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO-mimicking peptides inhibiting protein SUMOylation.
    Zhao B; Villhauer EB; Bhuripanyo K; Kiyokawa H; Schindelin H; Yin J
    Chembiochem; 2014 Dec; 15(18):2662-6. PubMed ID: 25412743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased SUMO-activating enzyme SAE1/UBA2 promotes glycolysis and pathogenic behavior of rheumatoid fibroblast-like synoviocytes.
    Wang C; Xiao Y; Lao M; Wang J; Xu S; Li R; Xu X; Kuang Y; Shi M; Zou Y; Wang Q; Liang L; Zheng SG; Xu H
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32938830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthocyanin-containing purple-fleshed potatoes suppress colon tumorigenesis via elimination of colon cancer stem cells.
    Charepalli V; Reddivari L; Radhakrishnan S; Vadde R; Agarwal R; Vanamala JK
    J Nutr Biochem; 2015 Dec; 26(12):1641-9. PubMed ID: 26383537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Products as a Promising Therapeutic Strategy to Target Cancer Stem Cells.
    Erkisa M; Sariman M; Geyik OG; Geyik C; Stanojkovic T; Ulukaya E
    Curr Med Chem; 2022; 29(4):741-783. PubMed ID: 34182899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia.
    Dong S; Chen J
    BMC Cancer; 2015 Nov; 15():893. PubMed ID: 26559765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.